Industry Requests Decreased Filing Burden For Improved Analytical Methods
Executive Summary
FDA should consider a decreased filing burden for improved post-approval analytical methods, industry participants contended at a recent FDA/American Association of Pharmaceutical Scientists workshop on packaging and analytical methods post-approval changes.